Ads
related to: latest news on heartburn medicine for seniors
Search results
Results from the WOW.Com Content Network
The drug, approved over four decades ago, had became the world's best selling medicine in 1988 and one of the first-ever drugs to top $1 billion in annual sales.
NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people ...
Ranitidine, a heartburn medicine sold under the brand name Zantac among others, was pulled from shelves in 2019, [1] following disclosure [2] of potential carcinogenic effects, [3] [4] which its manufacturers were accused of "engaging in a decades-long scheme to conceal." [5]
First approved in 1983, Zantac, sold at different times by GSK, Pfizer, Sanofi and Boehringer Ingelheim, became the world's best-selling medicine in 1988 and one of the first to top $1 billion in ...
All Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, the Food and Drug Administration announced Wednesday.
Since Tums is an over-the-counter drug, it is not considered a pharmaceutical-grade treatment (does not require a prescription). Prescription strength acid reflux medications often contain proton-pump inhibitors (PPI) or histamine H 2 receptor blockers (H 2 blockers, H 2 antagonists).
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: latest news on heartburn medicine for seniors